Clustering data with hclust algorithm for Targeted Sphingolipid analysis of human Fibroblasts silenced for or overexpressing GOLPH3 (Study ST001672)

Normal phase POSITIVE ION MODE (Analysis AN002730)
MetaboliteStructureF1F2F3
C16Lact-CerME3909981.230.771.01
C18Lact-CerME3910031.130.841.04
C18-SMME3909871.011.010.97
C20_1HexosylCerME3910050.971.040.98
C22_1Lact-CerME3910070.991.030.98
C24_1-SMME3909920.991.030.98
C16-SMME3909850.921.051.03
C18_1HexosylCerME3910010.951.080.97
C22_1-SMME3909900.921.081.00
C14HexosylCerME3909970.851.011.13
C14-SMME3909840.921.011.08
C18_1-SMME3909860.920.971.11
C24Lact-CerME3910151.290.900.81
C24_1Lact-CerME3910111.180.940.88
C26_1Lact-CerME3910141.121.000.88
C26Lact-CerME3910181.100.990.91
C22Lact-CerME3910101.111.060.83
C26_cerME3909831.031.090.88
C18_cerME3909750.591.211.20
C22_1_cerME3909780.601.211.19
C20_cerME3909770.591.171.23
C18_1_cerME3909740.631.171.20
C20_1_cerME3909760.641.151.21
C16_cerME3909730.581.401.02
C14_cerME3909720.621.321.06
C22_cerME3909790.661.301.04
C22HexosylCerME3910120.721.500.78
C20HexosylCerME3910080.811.390.80
C24HexosylCerME3910170.811.390.79
C24_cerME3909810.911.250.84
C26HexosylCerME3910190.891.310.80
C24-SMME3909930.931.140.93
C22_1HexosylCerME3910090.851.220.93
C24_1HexosylCerME3910130.831.240.93
C18HexosylCerME3910040.891.190.92
C22-SMME3909910.901.190.90
C26_1_cerME3909820.891.210.90
C26-SMME3909950.881.230.89
C16HexosylCerME3910000.751.171.08
C26_1HexosylCerME3910160.751.340.91
C24_1_cerME3909800.731.271.00
C20_1-SMME3909880.771.250.98
C26_1-SMME3909940.801.250.95

Factors:

F1Treatment:GOLPH3 overexpression
F2Treatment:GOLPH3 silencing
F3Treatment:no treatment
Data matrix
  logo